Clinical Trials Browser

Phase 2 × OTHER_GOV × Trifluridine × Clear all

NCT06293014 2024-03-05

TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms